Teleflex to present at World Congress on Vascular Access 2014 (“WoCoVA”) in Berlin
June 16 2014 - 7:00AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider
of medical devices for critical care, urology and surgery, will
present its ARROW® brand portfolio including PICCs
and CVCs with Chlorag+ard® Technology, which provides
antimicrobial and antithrombogenic protection, ARROW® VPS™ tip
location system and the new EZ-IO® Needle +
Stabilizer Kit at the World Congress on Vascular Access in Berlin,
Germany on June 18-20, 2014.
At the WoCoVA on June 18-20, Teleflex will present innovative
ARROW® brand products that are inspired by the goal of zero
complications in vascular care. This includes protection against
infection, thrombosis, occlusion and malposition.
At the booth, the Company will focus special attention on its
Chlorag+ard technology. This includes ARROW® JACC with Chlorag+ard®
technology, the world’s only antimicrobial and antithrombogenic CVC
and ARROW PICC with Chlorag+ard Technology, the world’s only
antimicrobial and antithrombogenic PICC. Additionally, the Company
will highlight the new EZ-IO® needle and stabilizer kit as well as
many educational innovations.
Three Symposia are scheduled, the first of which is to be held
on Wednesday, June 18, 13:00h – 14:00h, under the title “Starting a
Vascular Access Team. Why it makes sense and how to get started”.
The Speakers will be Prof. Dr. Bernhard Gebauer, MD, PhD; Germany;
Steve Hill, APRN; UK; Jim Lacy, BSN, RN, CRNI, VA-BC; U.S.A. - this
symposium can be joined in WoCoVA room B05-06.
This will be followed by the second Symposium on Thursday, June
19, at 07:30h – 08:30h, in WoCoVA room B05-06, under the title
“Antimicrobial Catheter Technologies – Fact or Fiction – A review
of Safety, Cost-effectiveness and Efficiencies”. The speakers are:
Dr. Giancarlo Scoppettuolo, MD, PhD, Italy; Kamna Giare-Patel;
U.S.A.; Dr. Philippe Burtin, MD, PhD, France and Dr. Tanjew
Stember, MD, PhD, Germany.
The third will take place on Thursday, June 19, 18:00 – 19:00,
WoCoVA room B08-09, the title being “Global Clinical Updates on the
Intraosseous route of Vascular Access”, with Chris Davlantes, MD,
FACEP; U.S.A., speaking.
During the general sessions, the Company will provide additional
information on catheter technologies, such as on the effectiveness
of eluting technology or non-eluting technology in preventing
thrombus accumulation and on the current role of central
coated/treated catheters with antibacterial/antiseptic drugs.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical
devices for a range of procedures in critical care, urology and
surgery. Our mission is to provide solutions that enable healthcare
providers to improve outcomes and enhance patient and provider
safety. Headquartered in Wayne, PA, Teleflex employs approximately
11,400 people worldwide and serves healthcare providers in more
than 150 countries. Additional information about Teleflex can be
obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, ARROW, VPS, EZ-IO, and Chlorag+ard are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates.
©2014 Teleflex Incorporated. All rights reserved.
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor
Relations610-948-2836jake.elguicze@teleflex.comwww.teleflex.comorMartina
Teichmann-ZindlerDirector Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.comwww.teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024